BioSpace News Archive

According to Report Study, the clinical oncology next generation sequencing market size is expected to surpass around USD 935 million by 2030 and is anticipated to grow at a CAGR of 15.8% during forecast period 2022 to 2030.

According to Report Study, the global Insulin Delivery Devices market size is expected to be worth around US$ 29.8 billion by 2030.

Veterinary Artificial Insemination Market study by “Data Bridge Market Research” provides details about the market dynamics affecting the Veterinary Artificial Insemination market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favourable competitive landscape and trends prevailing over the years.

Biomarker Technologies Market study by “Data Bridge Market Research” provides details about the market dynamics affecting the Biomarker Technologies market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favourable competitive landscape and trends prevailing over the years.

Laboratory Hoods and Enclosure Market study by “Data Bridge Market Research” provides details about the market dynamics affecting the Laboratory Hoods and Enclosure market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favourable competitive landscape and trends prevailing over the years.

A worldwide DNA Sequencing and Next-Generation Sequencing marketing document identifies, analyses, and estimates the up-and-coming trends along with major drivers, challenges and opportunities in the industry.

Molecular Biology Enzymes Market study by “Data Bridge Market Research” provides details about the market dynamics affecting the Molecular Biology Enzymes market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favourable competitive landscape and trends prevailing over the years.

An influential Surgical Instrument Tracking Systems Market report provides the segmentation of the global market on the basis of technology, application, product, and region. Each segment is explained through a chapter, which has been worded with careful thought to the ever-changing market dynamics.

Eargo, Inc. announced it has completed the issuance of $100 million aggregate principal amount of senior secured convertible notes to Patient Square Capital on June 28, 2022.

Mereo BioPharma Group plc announced that it has received a written notification from the Listing Qualifications Department of the Nasdaq Stock Market, LLC informing the Company that it has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5450 and the matter is closed.